Rohto Pharmaceutical
4527.T
#3600
Rank
NZ$6.78 B
Marketcap
NZ$30.14
Share price
-1.13%
Change (1 day)
4.60%
Change (1 year)

P/S ratio for Rohto Pharmaceutical (4527.T)

P/S ratio as of November 2026 (TTM): 1.66

According to Rohto Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.85. At the end of 2026 the company had a P/S ratio of 1.48.

P/S ratio history for Rohto Pharmaceutical from 2020 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20261.48-12.05%
20251.69-23.83%
20242.21-10.63%
20232.488.61%
20222.2815.31%
20211.98-0.57%
20201.99